Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted non AR mediated smart delivery of abiraterone to the prostate cancer. | PLoS One | 2022 | 36018864 | PubTator, text mining | PubMed |
| Refining the DC-targeting vaccination for preventing emerging infectious diseases. | Front Immunol | 2022 | 36016929 | PubTator, text mining | PubMed |
| The Cellular and Molecular Immunotherapy in Prostate Cancer. | Vaccines (Basel) | 2022 | 36016257 | PubTator, text mining | PubMed |
| Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review. | Vaccines (Basel) | 2022 | 36016136 | PubTator, text mining | PubMed |
| Cancer Immunotherapy and Delivery System: An Update. | Pharmaceutics | 2022 | 36015256 | PubTator, text mining | PubMed |
| Cuffless Blood Pressure Monitoring: Academic Insights and Perspectives Analysis. | Micromachines (Basel) | 2022 | 36014147 | PubTator, text mining | PubMed |
| STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer. | Cancers (Basel) | 2022 | 36011027 | PubTator, text mining | PubMed |
| Recent Advances and Challenges in Cancer Immunotherapy. | Cancers (Basel) | 2022 | 36010965 | PubTator, text mining | PubMed |
| Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease. | Biomedicines | 2022 | 36009418 | PubTator, text mining | PubMed |
| Aptamers as Theragnostic Tools in Prostate Cancer. | Biomolecules | 2022 | 36008950 | PubTator, text mining | PubMed |
| Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer. | Sci Rep | 2022 | 35948756 | PubTator, text mining | PubMed |
| Non-conducting functions of ion channels: The case of integrin-ion channel complexes. | Channels (Austin) | 2022 | 35942524 | PubTator, text mining | PubMed |
| Wearable Neck Surface Accelerometers for Occupational Vocal Health Monitoring: Instrument and Analysis Validation Study. | JMIR Form Res | 2022 | 35930317 | PubTator, text mining | PubMed |
| Antibody Diversity in Cancer: Translational Implications and Beyond. | Vaccines (Basel) | 2022 | 35893814 | PubTator, text mining | PubMed |
| The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer. | Biomedicines | 2022 | 35892678 | PubTator, text mining | PubMed |
| Purinergic Signaling in Oral Tissues. | Int J Mol Sci | 2022 | 35887132 | PubTator, text mining | PubMed |
| Tracking Prostate Carcinogenesis over Time through Urine Proteome Profiling in an Animal Model: An Exploratory Approach. | Int J Mol Sci | 2022 | 35886909 | PubTator, text mining | PubMed |
| Physical and in silico immunopeptidomic profiling of a cancer antigen prostatic acid phosphatase reveals targets enabling TCR isolation. | Proc Natl Acad Sci U S A | 2022 | 35878026 | PubTator, text mining | PubMed |
| Emerging Biomarker-Guided Therapies in Prostate Cancer. | Curr Oncol | 2022 | 35877260 | PubTator, text mining | PubMed |
| Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies. | Front Oncol | 2022 | 35875084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=16